Literature DB >> 7527886

Risperidone-induced neuroleptic malignant syndrome in young patient.

V Raitasuo, R Vataja, E Elomaa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527886     DOI: 10.1016/s0140-6736(94)90489-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Atypical Antipsychotics and the Risks of Acute Kidney Injury and Related Outcomes Among Older Adults: A Replication Analysis and an Evaluation of Adapted Confounding Control Strategies.

Authors:  Patrick B Ryan; Martijn J Schuemie; Darmendra Ramcharran; Paul E Stang
Journal:  Drugs Aging       Date:  2017-03       Impact factor: 3.923

Review 2.  Effects of newer antipsychotics on extrapyramidal function.

Authors:  Daniel Tarsy; Ross J Baldessarini; Frank I Tarazi
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

3.  Neuroleptic Malignant Syndrome: A Primary Care Perspective.

Authors:  Sanjay Gupta; Nikhil D Nihalani
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

Review 4.  Neuroleptic malignant syndrome associated with atypical antipsychotic drugs.

Authors:  Julian N Trollor; Xiaohua Chen; Perminder S Sachdev
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 5.  Adverse effects of antipsychotic agents. Do newer agents offer advantages?

Authors:  D G Owens
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

6.  Risperidone-Induced Renal Damage and Metabolic Side Effects: The Protective Effect of Resveratrol.

Authors:  Sedat Bilgiç; Deniz Taştemir Korkmaz; Sebile Azirak; Ayşe Nilay Güvenç; Nevin Kocaman; Mehmet Kaya Özer
Journal:  Oxid Med Cell Longev       Date:  2017-06-15       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.